Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06744621 · ClinicalTrials.gov registry record
Glucose Frequent of A1GDM in Labor
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 100
- Enrollment target
NCT06744621 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 100 participants.
The verdict
NCT06744621 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This is a prospective double arm study in patients with Gestational Diabetes Mellitus (GDM) utilizing frequent (single fingerstick on admission) vs infrequent glucose monitoring in labor (q 4 hours in latent labor and every 2 hours in active labor). Primary Objective: The primary outcome is glucose value of the neonate at birth. Secondary Objectives: Determine rates of insulin requirements within different monitoring techniques. Determine if there is a difference in neonatal intensive care unit (NICU) admission within different monitoring techniques. Determine neonatal blood glucose concentrations at 24 hours of life, number of glucose treatments, and neonatal hyperbilirubinemia. Secondary characteristics to be viewed for each diagnosis; BMI, race, age, and parity.
Interventions
- OTHER Fingerstick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-12-05 |
| Est. Completion | 2025-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06744621
The ClinicalTrials.gov registry entry for NCT06744621 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fingerstick is the first listed.
NCT06744621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06744621 about?
NCT06744621 is a clinical study titled "Glucose Frequent of A1GDM in Labor". This is a prospective double arm study in patients with Gestational Diabetes Mellitus (GDM) utilizing frequent (single fingerstick on admission) vs infrequent glucose monitoring in labor (q 4 hours in latent labor and every 2 hours in active labor). Primary Objective: The primary outcome is glucose ...
What is the current status of trial NCT06744621?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2024-12-05. Estimated completion is 2025-05-30.
What interventions are being tested in trial NCT06744621?
The interventions under investigation include: Fingerstick (OTHER).
Who is sponsoring clinical trial NCT06744621?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.